NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email India faces a surge in young-onset Type 2 diabetes due to sedentary lifestyles and processed diets, with over 101 million diagnosed and 130 million prRead More
‘Chronically online’ Gen Z turning to these hacks to fight brain rot, reduce social media usageApril 27, 2026